We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Establishment of the Early Intervention Program for Patients With Schizophrenia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00172770
First Posted: September 15, 2005
Last Update Posted: December 21, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Information provided by:
National Taiwan University Hospital
  Purpose

Schizophrenia is a severe mental illness, which has a prodromal phase of 1-2 years prior to the onset of the illness. During the prodromal phase, patients might show maladaptation and/or poor social functioning. However, these early symptom of schizophrenia might be overlooked by patients and their families. At that period, patients might strive to improve their social interactions and social functioning. However, the efforts might further create their stress level on everyday life, which can actually accelerate the illness onset of schizophrenia. In other words, the efforts would worsen the pathophysiologic changes in the brain, which can result in the positive symptoms of schizophrenia.

Previous researches found that the critical period for treatment of schizophrenia is the early phase of illness onset, especially the first two or three years. Delay treatment would worsen the illness. To this extent, early treatment would bring to a better prognosis as well as minimize the costs of individuals, families and society. In other words, early interventions not only can prevent relapse, it also can benefit patients’ psychosocial adjustments. However, researches found that the average duration of untreated psychosis is 25.2 months in Taiwan, which indicates the phenomena of delay treatment and this trend might result in missing the critical treatment period.

This is a two years study aiming to establish an early intervention program for patients with schizophrenia. In the first year, it aims to understand the phenomena of psychiatric care services utilization for patients with schizophrenia, special emphasis will be on the delay treatment and pluralistic health seeking process. In the second year, it aims to establish an early intervention program. The results of this research would contribute to in-service trainings, service providing, and policy making of psychiatric services.


Condition Phase
Schizophrenia Phase 1 Phase 2

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 20
Study Start Date: August 2004
Estimated Study Completion Date: July 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients with schizophrenia
  • capable to express in Chinese
  • willing to cooperate with

Exclusion Criteria:

  • patients with schizophrenia but not willing to cooperate with
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00172770


Contacts
Contact: Ping-Chuan Hsiung, Ph.D 02-23123456 ext 8430

Locations
Taiwan
Ping-Chuan,Hsiung Recruiting
Taipei, Taiwan, 106
Contact: Ping-Chuan Hsiung, Ph.D    02-23123456 ext 8430      
Sponsors and Collaborators
National Taiwan University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Investigators
Study Chair: Ping-Chuan Hsiung, Ph.D Department of Nursing, National Taiwan University
  More Information

ClinicalTrials.gov Identifier: NCT00172770     History of Changes
Other Study ID Numbers: 93621700617
DOH93-TD-M-113-032
First Submitted: September 12, 2005
First Posted: September 15, 2005
Last Update Posted: December 21, 2005
Last Verified: September 2005

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders